Researchers in Singapore have characterized the structure of telomeres, a key part of chromosomes that play a protective role for DNA. The findings could help explain why humans age and develop cancer and inform drug development.
“The organization of the proteins in telomeres, at the molecular level, revealed in this work, paves the way for further structural studies,” says Professor Lars Nordenskiöld, Chair of Nanyang Technological University (NTU)’s School of Biological Sciences. “This can shed light on the structure–function relationship of telomeres in the context of ageing and cancer. It can also provide a template to develop treatments for genetic diseases.”
Telomeres are protective caps at the ends of the DNA molecules that make up our chromosomes. Like the plastic tips on the ends of shoelaces, the telomeres’ function is to cap and protect the ends of the chromosome from damaging themselves by sticking to each other or fraying.
The NTU team discovered that the building blocks of telomeres are stacked in columns like a spring. They also found that the shape of telomeres leaves a part of the DNA exposed and unprotected, leaving it more susceptible to damage than previously thought. The study also discovered “elegant grooves” formed by DNA that suggest how remodeling might happen within telomeres, Nordenskiöld says. “This could provide a future platform for studies on drugs to target damage at the telomeric level,” Nordenskiöld says.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Previously, due to its chemical instability and complex repetitive nature, scientists have struggled to duplicate enough telomeric DNA in the laboratory to be able to use electron microscopes to observe how it is structured.
In the NTU study, published recently in Nature, the researchers adapted existing processes to replicate DNA and saw that in telomeres, the nucleosomes, which contain tightly packed strands of DNA (deoxyribonucleic acid), are stacked in columns around chromosomal proteins called histones.
“Our study showed that telomeres are not structured in the zig-zag formation as depicted in textbooks, but rather in columns and a spring formation,” Nordenskiöld says. “This leaves the crucial part of the DNA—its helix—exposed. This helps us understand how telomeres, despite their essential role in preventing damage to DNA, are themselves hotspots for DNA damage. Our study will help researchers and doctors understand the reasons behind how telomeres are damaged at a molecular level, as detailed research on the structure of the DNA within telomeres and external factors, such as proteins and other cell processes, is limited.”
To arrive at their results, the researchers used a state-of-the-art cryogenic electron microscope at the NTU Institute of Structural Biology to probe the structure of telomeres.
Besides growing knowledge of how telomeres are involved in processes such as aging and DNA damage, the findings by the NTU research team may also be useful in developing potential treatments for diseases that are caused by dysfunctional telomeres. These include aplastic anemia when the human body stops producing enough new blood cells and dyskeratosis congenita, a rare genetic form of bone marrow failure, and the inability of the marrow to produce sufficient blood cells, which typically results in death by the age of 30.
“A specific future focus in our study of DNA will be how our structure interacts with previously discovered telomere-specific factors, with a keen focus on factors associated with cancer development and longevity,” says Dr. Aghil Soman, Research Fellow at NTU’s School of Biological Sciences, who co-authored the study. “Our structure also provides an avenue to improve small molecule anticancer drugs. Armed with the structure of telomeric nucleosome assemblies, we can now potentially design anticancer drugs that solely target telomeres with high affinity. This would help overcome the limitation of drugs like cisplatin, which although it kills cancer cells in humans, also causes damage to the kidneys, liver, and brain.”